How Interferon-Alpha Treats Rare Blood Cancers: New Study Findings
Interferon-alpha treats myeloproliferative neoplasms such as essential thrombocythemia by forcing mutant blood stem cells to rapidly mature into short-lived neutrophils, according to a study published in Nature Genetics by Weill Cornell Medicine investigators. The biologic drug also balances myeloid and lymphoid cell production while depleting malignant cell pools in the bone marrow, though its broad … Read more